Limiting factors in the localization of tumours with radiolabelled antibodies
- 31 May 1985
- journal article
- Published by Elsevier in Immunology Today
- Vol. 6 (5), 163-170
- https://doi.org/10.1016/0167-5699(85)90146-x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Model for the Radioimmunodetection of TumoursProtides of the Biological Fluids, 1984
- Localisation of metastatic carcinoma by a radiolabelled monoclonal antibodyBritish Journal of Cancer, 1983
- Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.BMJ, 1982
- Tumor localization of CEA-containing human tumors in nude mice by means of monoclonal anti-CEA antibodiesInternational Journal of Cancer, 1982
- LIPOSOMALLY ENTRAPPED SECOND ANTIBODY IMPROVES TUMOUR IMAGING WITH RADIOLABELLED (FIRST) ANTITUMOUR ANTIBODYThe Lancet, 1982
- Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphyImmunology Today, 1981
- Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigenBritish Journal of Cancer, 1981
- Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with CarcinomaNew England Journal of Medicine, 1980
- Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.BMJ, 1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978